<DOC>
	<DOC>NCT00297505</DOC>
	<brief_summary>The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.</brief_summary>
	<brief_title>Serotonin, Impulsivity, and Cocaine Dependence Treatment</brief_title>
	<detailed_description>Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>male and female subjects age 18 to 50 who currently meet DSMIV criteria for cocaine dependence. female subjects: a negative pregnancy test current or past DSMIV Axis I disorder other than substance abuse/dependence any serious nonpsychiatric medical illness requiring ongoing medical treatment substance dependence other than cocaine within the last 3 months negative urine drug screen for cocaine at time of testing for female subjects: a positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>Cocaine; citalopram; impulsivity; serotonin</keyword>
</DOC>